J. Goldman & Co LP - AZURRX BIOPHARMA INC ownership

AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 17 filers reported holding AZURRX BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of AZURRX BIOPHARMA INC
ValueSharesWeighting
Q2 2019$1,101,000
-21.4%
647,770
+12.0%
0.08%
-3.8%
Q1 2019$1,400,000
+109.9%
578,398
+4.9%
0.08%
+54.9%
Q4 2018$667,000
-39.0%
551,358
+29.6%
0.05%
-32.9%
Q3 2018$1,093,000
-37.3%
425,358
-21.6%
0.08%
-15.6%
Q2 2018$1,742,000
+515.5%
542,550
+502.8%
0.09%
+650.0%
Q1 2018$283,000
-60.1%
90,000
-53.8%
0.01%
-67.6%
Q4 2017$709,000
-13.4%
194,932
-5.0%
0.04%
-9.8%
Q3 2017$819,000
+149.7%
205,157
+151.7%
0.04%
+127.8%
Q2 2017$328,00081,4930.02%
Other shareholders
AZURRX BIOPHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Pensionmark Financial Group, LLC 80,000$90,0000.03%
PARSONS CAPITAL MANAGEMENT INC/RI 178,203$161,0000.02%
Waldron Private Wealth LLC 69,835$63,0000.01%
ARDSLEY ADVISORY PARTNERS LP 30,000$27,0000.01%
Patriot Financial Group Insurance Agency, LLC 15,250$14,0000.01%
TIEDEMANN ADVISORS, LLC 63,460$57,0000.00%
Squarepoint Ops LLC 39,439$36,0000.00%
Tower Research Capital LLC (TRC) 15,557$14,0000.00%
BlackRock Inc. 15,332$14,0000.00%
Renaissance Technologies 143,500$130,0000.00%
View complete list of AZURRX BIOPHARMA INC shareholders